Table 1.

Individual study characteristics among Caucasians according to primary phenotype (lung cancer)

Stage	Study	Location	Study period	Study design	Case no.	Control no.	Genotyping platform
Discovery (3,953 cases and  4,730 controls)	Toronto	GTA, Canada	1997–2002	Population and Hospital CC	331	499	Illumina HumanHap300
	IARC	Central Europe	1998–2002	Hospital CC	1,964	2,610	Illumina HumanHap300
	MDACC	Texas, USA	1997–2007	Hospital CC	1,154	1,137	Illumina HumanHap300
	HMGU	Germany	2000–2008 (LUCY)	Population CC	504	484	Illumina HumanHap550
			1990–1998 (KORA)
			1997–2007 (Heidelberg)
Replication (7,510 cases and 7,476  controls)	NCI (dbGaP)	USA and Italy	1985–2005	Population CC	5,699	5,815	HumanHap550v3.0
							Human610_Quadv_1_B
							Human1M_Duov3_b
							HumanHap300v1.1
							HumanHap250Sv1.0
	MSH-PMH	Toronto, Canada	2009–2013	Clinic CC	1,073	939	Axiom array
	MEC	USA	1993–1996	Nested CC	215	225	Axiom array
	Harvard	USA	1990–2006	Nested CC	523	497	Axiom array